Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

‍

Smithsonian follows up on the story of EISAI and Biogen's new drug, lecanemab. The Alzheimer’s Association stated, “These are the most encouraging results in clinical trials treating the underlying causes of Alzheimer’s to date.”

Meanwhile, Forbes examines HumanFirst, a company offering academic researchers free access to its clinical research image library.

With new legislation in India called the "New Drugs, Medical Devices and Cosmetics Bill," Sreeja Ramesh argues the law needs to be separate legislation. (BizzBuzz)

The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!

‍

‍

Our Culture

“My favorite thing about working for AG Mednet is our diversity; the potential to grow, and to learn."

      –Sirisha, Software Engineer

‍‍

‍

‍

About Judi

Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.